Fundraising FoxSenseonics
NASDAQ: SENSGermantown, US · Delaware corporation · 1 known investors
Find your way into Senseonics
Sign up to see every warm intro you have to Senseonics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Senseonics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Senseonics develops and commercializes an implantable continuous glucose monitoring system called Eversense that measures blood glucose levels for extended periods (up to 12 months) via a subcutaneous sensor and rechargeable transmitter, serving people with diabetes as an alternative to conventional CGM devices that require replacement every 1-2 weeks.
Founders & leadership
MP
Mirasol PanlilioExecutiveMirasol Panlilio is an executive with more than two decades of experience in medical diagnostics, having held leadership roles focused on strategic planning, product development, commercialization, and international sales and marketing.
RD
R. Don ElseyExecutive
MJ
Mukul JainExecutive
TT
Timothy T. GoodnowExecutive
BH
Brian HansenChief Commercial Officer
Board
DA
Douglas A. RoederBoard director
MJ
PJ
Peter Justin KleinBoard director
JW
John W. LittlechildBoard director
EF
Ed FiorentinoBoard director
SP
Stephen P. DeFalcoBoard director
Investors · 1
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40M
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20.2M disclosed across 3 of 4 rounds · 2014–2026
▶$10MraisedAug 2015 · 10 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2015 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mirasol PanlilioExecutive Officer
- Ed FiorentinoDirector
- Douglas A. RoederDirector
- M. James BarrettDirector
- Stephen P. DeFalcoDirector
- R. Don ElseyExecutive Officer
- Peter Justin KleinDirector
- John W. LittlechildDirector
- Mukul JainExecutive Officer
- Francis H. ZenieDirector
- Timothy T. GoodnowExecutive Officer, Director
- Doug PrinceDirector
- Offering amount
- $12.5M
- Amount sold
- $10M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedAug 2014 · 1 investors · BiotechnologyRule 506(b)
▶$300KraisedAug 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas A. RoederDirector
- Ed FiorentnoDirector
- Francis H. ZenieDirector
- Peter Justin KleinDirector
- John W. LittlechildDirector
- Stephen P. DeFalcoDirector
- M. James BarrettDirector
- Timothy T. GoodnowExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.9MraisedJun 2014 · 11 investors · BiotechnologyRule 506(b)
▶$9.9MraisedJun 2014 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Francis H. ZenieDirector
- Douglas A. RoederDirector
- M. James BarrettDirector
- Timothy T. GoodnowExecutive Officer, Director
- Stephen P. DeFalcoDirector
- Ed FiorentinoDirector
- Peter Justin KleinDirector
- John W. LittlechildDirector
- Offering amount
- $23.6M
- Amount sold
- $9.9M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Senseonics do?
- Senseonics develops and commercializes an implantable continuous glucose monitoring system called Eversense that measures blood glucose levels for extended periods (up to 12 months) via a subcutaneous sensor and rechargeable transmitter, serving people with diabetes as an alternative to conventional CGM devices that require replacement every 1-2 weeks.
- Who are Senseonics's investors?
- Senseonics's investors include New Enterprise Associates (NEA).
- How much funding has Senseonics raised?
- Senseonics has disclosed $20.2M raised across 3 of its 4 known rounds.
- Where is Senseonics headquartered?
- Senseonics is headquartered in Germantown, US.